Yukiko Miyamoto
Overview
Explore the profile of Yukiko Miyamoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
1829
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Fajtova P, Hurysz B, Miyamoto Y, Serafim M, Jiang Z, Trujillo D, et al.
bioRxiv
. 2023 Apr;
PMID: 37066163
The protozoan parasite, (Tv) causes trichomoniasis, the most common, non-viral, sexually transmitted infection in the world. Only two closely related drugs are approved for its treatment. The accelerating emergence of...
12.
Russell B, Brown S, Siguenza N, Mai I, Saran A, Lingaraju A, et al.
Cell
. 2022 Aug;
185(17):3263-3277.e15.
PMID: 35931082
Live bacterial therapeutics (LBTs) could reverse diseases by engrafting in the gut and providing persistent beneficial functions in the host. However, attempts to functionally manipulate the gut microbiome of conventionally...
13.
Ihara S, Miyamoto Y, Le C, Tran V, Hanson E, Fischer M, et al.
PLoS Negl Trop Dis
. 2022 Apr;
16(4):e0010323.
PMID: 35468132
Giardia lamblia is a leading protozoal cause of diarrheal disease worldwide. Infection is associated with abdominal pain, malabsorption and weight loss, and protracted post-infectious syndromes. A human vaccine is not...
14.
Zhou J, Miyamoto Y, Ihara S, Kroll A, Nieskens N, Tran V, et al.
J Infect Dis
. 2022 Mar;
226(2):319-323.
PMID: 35262728
The protozoan pathogen Giardia lamblia is an important worldwide cause of diarrheal disease and malabsorption. Infection is managed with antimicrobials, although drug resistance and treatment failures are a clinical challenge....
15.
Krakovka S, Ribacke U, Miyamoto Y, Eckmann L, Svard S
Front Microbiol
. 2022 Feb;
13:834008.
PMID: 35222342
Metronidazole (MTZ) is a clinically important antimicrobial agent that is active against both bacterial and protozoan organisms. MTZ has been used extensively for more than 60 years and until now...
16.
Yagi K, Imamura T, Tada H, Liu J, Miyamoto Y, Ohbatake A, et al.
J Diabetes Investig
. 2022 Jan;
13(6):1052-1061.
PMID: 35092353
Aims/introduction: Diastolic cardiac dysfunction in type 2 diabetes (DD2D) is a critical risk of heart failure with preserved ejection fraction. However, there is no established biomarker to detect DD2D. We...
17.
Hartmann P, Duan Y, Miyamoto Y, Demir M, Lang S, Hasa E, et al.
Hepatol Int
. 2022 Jan;
16(2):359-370.
PMID: 35075592
Background: Obesity, non-alcoholic fatty liver disease (NAFLD) and its more advanced form non-alcoholic steatohepatitis (NASH) are important causes of morbidity and mortality worldwide. Bile acid dysregulation is a pivotal part...
18.
Orecchioni M, Kobiyama K, Winkels H, Ghosheh Y, McArdle S, Mikulski Z, et al.
Science
. 2022 Jan;
375(6577):214-221.
PMID: 35025664
Atherosclerosis is an inflammatory disease of the artery walls and involves immune cells such as macrophages. Olfactory receptors (OLFRs) are G protein–coupled chemoreceptors that have a central role in detecting...
19.
Demir M, Lang S, Hartmann P, Duan Y, Martin A, Miyamoto Y, et al.
J Hepatol
. 2021 Dec;
76(4):788-799.
PMID: 34896404
Background & Aims: Studies investigating the gut-liver axis have largely focused on bacteria, whereas little is known about commensal fungi. We characterized fecal fungi in patients with non-alcoholic fatty liver...
20.
Natto M, Miyamoto Y, Munday J, AlSiari T, Al-Salabi M, Quashie N, et al.
Mol Microbiol
. 2021 Nov;
116(6):1489-1511.
PMID: 34738285
Trichomoniasis is a common and widespread sexually-transmitted infection, caused by the protozoan parasite Trichomonas vaginalis. T. vaginalis lacks the biosynthetic pathways for purines and pyrimidines, making nucleoside metabolism a drug...